ZNF154 and neoplasm: Moreover, our in silico analyses suggest that ZNF154 methylation can be used to detect tumor signal in plasma samples as well, with a predicted AUC of up to 0.96 when ctDNA accounts for as little as 1% of cell-free DNA (cfDNA), for colon, lung, breast, stomach, and endometrial tumors3.